We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$622M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$597M
3
CMCSA icon
Comcast
CMCSA
+$461M
4
UNH icon
UnitedHealth
UNH
+$409M
5
MXIM
Maxim Integrated Products
MXIM
+$343M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CUZ icon
10751
Cousins Properties
CUZ
$4.89B
$330K ﹤0.01%
8,844
-67,478
-88% -$2.6M
PCVX icon
10752
CALL
Vaxcyte
PCVX
$8.64B
$330K ﹤0.01%
13,000
+1,700
+15% +$41.2K
RAPT
10753
DELISTED
RAPT Therapeutics
RAPT
$330K ﹤0.01%
+1,328
New +$351K
CRUZ
10754
DELISTED
Defiance Hotel, Airline, and Cruise ETF
CRUZ
$330K ﹤0.01%
+14,654
New +$320K
KRTX
10755
PUT
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$330K ﹤0.01%
2,700
-4,100
-60% -$473K
ZYNE
10756
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$330K ﹤0.01%
77,843
-5,639
-7% -$25.2K
BLU
10757
PUT
DELISTED
BELLUS Health Inc.
BLU
$330K ﹤0.01%
+53,800
New +$204K
IBTA
10758
DELISTED
iShares iBonds Dec 2021 Term Treasury ETF
IBTA
$330K ﹤0.01%
+13,029
New +$330K
DFH icon
10759
PUT
Dream Finders Homes
DFH
$1.42B
$329K ﹤0.01%
19,000
+500
+3% +$10.4K
NJAN icon
10760
Innovator Growth-100 Power Buffer ETF January
NJAN
$356M
$329K ﹤0.01%
7,988
-50,000
-86% -$2.06M
PSQ icon
10761
PUT
ProShares Short QQQ
PSQ
$636M
$329K ﹤0.01%
5,400
+1,700
+46% +$101K
SAN icon
10762
CALL
Banco Santander
SAN
$210B
$329K ﹤0.01%
90,900
+59,100
+186% +$218K
BKU icon
10763
Bankunited
BKU
$3.44B
$328K ﹤0.01%
7,838
-10,057
-56% -$412K
CTKB icon
10764
Cytek Biosciences
CTKB
$610M
$328K ﹤0.01%
+15,318
New +$360K
GALT icon
10765
CALL
Galectin Therapeutics
GALT
$347M
$328K ﹤0.01%
84,500
+27,800
+49% +$94.2K
GTY
10766
CALL
Getty Realty Corp
GTY
$2.05B
$328K ﹤0.01%
11,200
-4,200
-27% -$131K
RUN icon
10767
Sunrun
RUN
$2.45B
$328K ﹤0.01%
7,462
-688,113
-99% -$32.8M
TLYS icon
10768
PUT
Tilly's
TLYS
$122M
$328K ﹤0.01%
+23,400
New +$355K
WCLD
10769
PUT
WisdomTree Cloud Computing Fund
WCLD
$311M
$328K ﹤0.01%
5,700
-5,100
-47% -$299K
KBUY
10770
DELISTED
KraneShares CICC China Consumer Leaders Index ETF
KBUY
$328K ﹤0.01%
13,864
-74,355
-84% -$1.78M
OBSV
10771
DELISTED
ObsEva SA Ordinary Shares
OBSV
$328K ﹤0.01%
105,661
-149
-0.1% -$422
ADUS icon
10772
PUT
Addus HomeCare
ADUS
$2.17B
$327K ﹤0.01%
4,100
-2,800
-41% -$243K
FRMM
10773
PUT
Forum Markets
FRMM
$80.4M
$327K ﹤0.01%
16
+3
+23% +$82K
EAOA
10774
DELISTED
iShares ESG Aware Aggressive Allocation ETF
EAOA
$327K ﹤0.01%
9,901
-26,411
-73% -$892K
FTDS icon
10775
First Trust Dividend Strength ETF
FTDS
$39.9M
$327K ﹤0.01%
6,919
-766
-10% -$37K
429 430
431
432 433

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.